Hardware, data, and foundation models — how China's supply chain density, state-backed industrial policy, and EV-adjacent manufacturing base have made it the world's humanoid production capital.
Read the report →In 2025, Chinese companies shipped roughly 80% of the world's humanoid robots. In 2026, that share is projected to rise as Unitree and AgiBot alone target 75,000+ unit annual capacity — more than the entire Western supply combined.
The Chinese robotics market reached $14.2B in 2026, up 47% year-over-year — the fastest growth of any major economy. Unit shipments tell an even starker story: Shanghai's AgiBot led the world with 5,168 humanoid units in 2025 (39% global share per Omdia), followed by Hangzhou's Unitree at 5,500 (Unitree's own figure disputes Omdia's second-place ranking). Combined with UBTECH (7% share) and Leju (~5%), Chinese firms control nearly 90% of global humanoid installations.
Three forces define China's position. First, supply chain integration: the Yangtze River Delta hosts the world's most vertically integrated humanoid supply chain — Unitree manufactures motors, reducers, and sensors in-house; component suppliers (DJI, DeepSeek, EV actuator makers) are within 2-hour logistics radius. Second, national policy coordination: the 2025 Humanoid Robot Action Plan, issued by MIIT and five ministries, targets 100,000 deployed humanoids by 2027. Third, demand-side scale: BYD (world's largest EV maker), CATL (dominant battery manufacturer), and Foxconn alone represent demand for tens of thousands of systems.
A prototype that takes 12 weeks to produce in the US or Germany is turned around in 10–14 days in Shenzhen, at a fraction of the cost. The same EV component supply chain that made China the world's largest car manufacturer now serves humanoids — actuators, gears, precision motors can often be repurposed directly between the two.
Manufacturing scale, supply-chain vertical integration, and national industrial policy — the gravitational center of global robotics production.
The China robotics market reached $14.2B in 2026, growing +47% year-over-year. This trajectory reflects the confluence of labor-market dynamics, policy incentives, and foundation-model-enabled deployment velocity discussed throughout this report.
Unit shipments tell a more revealing story than market dollars. Below, SVRC's view of the 2025 competitive landscape for humanoid and leading-category robotics in China, shown alongside relevant global comparisons where instructive.
Every robotics market has its flagship firms — the companies whose trajectory shapes the country's narrative and around which an ecosystem of suppliers, talent, and capital clusters.
Where robots are actually working in China today — and where growth is accelerating fastest. SVRC's estimates reflect operational stock, not cumulative installations.
| Vertical | Deployed Units (2025E) | YoY Growth | Leading Form Factor |
|---|---|---|---|
| EV / Automotive | 28,000 | +42% | Precision 6-DoF + humanoid |
| Electronics (Foxconn etc.) | 19,500 | +35% | Bimanual arm system |
| Battery (CATL, BYD) | 12,500 | +51% | Precision arm + inspection |
| Logistics / JD, Cainiao | 8,200 | +39% | Mobile manipulator |
| General Manufacturing | 5,800 | +28% | Fixed industrial arm |
| Consumer / Retail demo | 3,400 | +124% | Humanoid (demo/PR) |
A candid assessment of what China does best in global robotics — and where structural vulnerabilities require attention.
The flow of venture capital, strategic corporate investment, and public funding that shapes robotics competitiveness in China.
In 2025, Chinese humanoid-related investment reached 39.8B RMB (~$5.5B) across 325 deals — 326% year-over-year growth. Unitree closed Series C at $3B valuation targeting $7B at IPO. Galbot raised over $300M. First twenty days of January 2026 saw 18 humanoid stocks with net inflows exceeding 100M RMB each. Capital availability is no longer the bottleneck; operational execution is.
Globally, investors increasingly cite proprietary data collection infrastructure as the primary defensibility argument in robotics. The question for China specifically: do its robotics companies generate deployment-specific data at a rate that compounds faster than foundation model improvements erode it? This is the question that 2026–2027 will answer.
Four themes SVRC's research team believes will define China's robotics trajectory over the next 18 months.
A successful STAR market listing at $7B valuation would lift the entire Chinese robotics supply chain and likely trigger follow-on IPOs from AgiBot, XPENG Robotics, and Fourier.
Expect new US restrictions on Chinese humanoids in 2026–2027, mirroring semiconductor and EV playbooks. This accelerates rather than blocks domestic demand.
Unitree R1 at $5,900 is the opening salvo. 2027 likely sees sub-$5K consumer-grade humanoids from multiple Chinese firms — a price point that is categorically impossible for Western makers.
Huawei Ascend and domestic inference accelerators will increasingly replace NVIDIA Jetson in Chinese humanoids. Performance gap is closing; supply is reliable.
China's robotics trajectory in 2026–2027 will be defined less by hardware breakthroughs than by whether the country can convert its distinctive advantages into repeatable deployment outcomes — at the speed that Chinese and US competitors are setting. The window for structural positioning is narrowing.
Whether you're an enterprise evaluating deployment, a manufacturer considering market entry, or an investor sizing the opportunity — SVRC partners on hardware sourcing, data collection programs, policy navigation, and on-the-ground deployment coordination.